SCHEMBL3535514

SCHEMBL3535514

CN1CCCC1CCS

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19376421 0.81 CYP1A2 (0.57)
SCHEMBL24350484 0.81
SCHEMBL10593132 0.81
SCHEMBL10593142 0.81
SCHEMBL11926 0.79
SCHEMBL60463 0.79
SCHEMBL11921 0.79
SCHEMBL21430668 0.78 ALDH1A1 (0.56)
SCHEMBL12847833 0.78 CYP1A2 (0.50)
Bromide SCHEMBL28177608 0.78 CYP1A2 (0.55)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1747203-A4 SCALABLE SYNTHESIS OF IMIDAZOLE DERIVATIVES JANSSEN PHARMACEUTICA NV (BE) 2009-04-22 EP claimed
US-7507756-B2 Scalable synthesis of imidazole derivatives JANSSEN PHARMACEUTICA N.V. (BE) 2009-03-24 US claimed
EP-1747203-A1 SCALABLE SYNTHESIS OF IMIDAZOLE DERIVATIVES JANSSEN PHARMACEUTICA N.V. (BE) 2007-01-31 EP claimed
WO-2005110998-A1 SCALABLE SYNTHESIS OF IMIDAZOLE DERIVATIVES JANSSEN PHARMACEUTICA N.V. (BE) 2005-11-24 WO claimed
US-20050250948-A1 Scalable synthesis of imidazole derivatives JANSSEN PHARMACEUTICA N.V. (BE) 2005-11-10 US claimed
US-20240366518-A1 COMPOUNDS, COMPOSITIONS, AND METHODS OF USING THEREOF LIFE EDIT THERAPEUTICS, INC. 2024-11-07 US disclosed
CN-118324715-A Compounds, compositions, and methods of use thereof 艾勒维生技公司 2024-07-12 CN disclosed
US-20240173267-A1 COMPOUNDS, COMPOSITIONS, AND METHODS OF USING THEREOF ONCORUS, INC. (US) 2024-05-30 US disclosed
CN-117750962-A Compounds, compositions, and methods of use thereof 艾勒维生技公司 2024-03-22 CN disclosed
EP-4291201-A1 COMPOUNDS, COMPOSITIONS, AND METHODS OF USING THEREOF Oncorus, Inc. (US) 2023-12-20 EP disclosed
WO-2022173531-A9 COMPOUNDS, COMPOSITIONS, AND METHODS OF USING THEREOF ONCORUS, INC. (US) 2023-03-02 WO disclosed
WO-2022173531-A1 COMPOUNDS, COMPOSITIONS, AND METHODS OF USING THEREOF ONCORUS, INC. (US) 2022-08-18 WO disclosed
US-20090143591-A1 SCALABLE SYNTHESIS OF IMIDAZOLE DERIVATIVES JANSSEN PHARMACEUTICA NV (BE) 2009-06-04 US disclosed
EP-1747203-A4 SCALABLE SYNTHESIS OF IMIDAZOLE DERIVATIVES JANSSEN PHARMACEUTICA NV (BE) 2009-04-22 EP disclosed
US-7507756-B2 Scalable synthesis of imidazole derivatives JANSSEN PHARMACEUTICA N.V. (BE) 2009-03-24 US disclosed
EP-1747203-A1 SCALABLE SYNTHESIS OF IMIDAZOLE DERIVATIVES JANSSEN PHARMACEUTICA N.V. (BE) 2007-01-31 EP disclosed
WO-2005110998-A1 SCALABLE SYNTHESIS OF IMIDAZOLE DERIVATIVES JANSSEN PHARMACEUTICA N.V. (BE) 2005-11-24 WO disclosed
US-20050250948-A1 Scalable synthesis of imidazole derivatives JANSSEN PHARMACEUTICA N.V. (BE) 2005-11-10 US disclosed
US-4618599-A WATER SOLUBILITY RHONE-POULENC SANTE (FR) 1986-10-21 US disclosed
US-4617377-A BACTERICIDES RHONE-POULENC SANTE (FR) 1986-10-14 US disclosed